| Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01 A Soran, V Ozmen, S Ozbas, H Karanlik, M Muslumanoglu, A Igci, ... Annals of surgical oncology 25, 3141-3149, 2018 | 301 | 2018 |
| The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases F Ozkalemkas, R Ali, V Ozkocaman, T Ozcelik, U Ozan, H Ozturk, E Kurt, ... BMC cancer 5, 1-9, 2005 | 165 | 2005 |
| Randomized trial comparing locoregional resection of primary tumor with no surgery in stage IV breast cancer at the presentation (Protocol MF07‐01): a study of Turkish … A Soran, S Ozbas, SF Kelsey, BM Gulluoglu The breast journal 15 (4), 399-403, 2009 | 98 | 2009 |
| Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: a prospective pilot study M Demiray, EE Ulukaya, M Arslan, S Gokgoz, O Saraydaroglu, I Ercan, ... Cancer investigation 24 (7), 669-676, 2006 | 93 | 2006 |
| A randomized controlled trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer: Turkish Study (Protocol MF07-01). A Soran, V Ozmen, S Ozbas, H Karanlik, M Muslumanoglu, A Igci, ... Journal of Clinical Oncology 34 (15_suppl), 1005-1005, 2016 | 83 | 2016 |
| Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients B Tunca, G Tezcan, G Cecener, U Egeli, A Zorluoglu, T Yilmazlar, S Ak, ... Journal of cancer research and clinical oncology 139, 691-702, 2013 | 76 | 2013 |
| Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy AB Şahin, E Cubukcu, B Ocak, A Deligonul, S Oyucu Orhan, S Tolunay, ... Scientific Reports 11 (1), 14662, 2021 | 74 | 2021 |
| Abstract S2-03: Early follow up of a randomized trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer; Turkish study … A Soran, V Ozmen, S Ozbas, H Karanlik, M Muslumanoglu, A Igci, ... Cancer Research 73 (24_Supplement), S2-03-S2-03, 2013 | 70 | 2013 |
| Primary Neuroendocrine Small Cell Carcinomaof the Breast B Samli, S Celik, T Evrensel, B Orhan, I Tasdelen Archives of pathology & laboratory medicine 124 (2), 296-298, 2000 | 69 | 2000 |
| Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer: a single center randomized study O Kanat, T Evrensel, I Baran, H Coskun, M Zarifoglu, OF Turan, E Kurt, ... Medical Oncology 20, 237-245, 2003 | 63 | 2003 |
| Primary surgery with systemic therapy in patients with de novo stage IV breast cancer: 10-year follow-up; protocol MF07-01 randomized clinical trial A Soran, V Ozmen, S Ozbas, H Karanlik, M Muslumanoglu, A Igci, ... Journal of the American College of Surgeons 233 (6), 742-751. e5, 2021 | 57 | 2021 |
| Association of breast cancer and cytokine gene polymorphism in Turkish women G Gönüllü, B Baştürk Saudi Medical Journal, 2007 | 54 | 2007 |
| Ficus carica Latex Prevents Invasion Through Induction of Let-7d Expression in GBM Cell Lines G Tezcan, B Tunca, A Bekar, M Yalcin, S Sahin, F Budak, G Cecener, ... Cellular and molecular neurobiology 35, 175-187, 2015 | 50 | 2015 |
| Single-agent irinotecan as second-line treatment for advanced gastric cancer O Kanat, T Evrensel, O Manavoglu, M Demiray, E Kurt, G Gonullu, M Kiyici, ... Tumori Journal 89 (4), 405-407, 2003 | 43 | 2003 |
| Evaluation of lung cancer metastases to the spine U Aydinli, CL Ozturk, S Bayram, S Sarihan, T Evernsel, HS Yilmaz Acta orthopaedica belgica 72 (5), 592, 2006 | 41 | 2006 |
| 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy E Alper, M Gurel, T Evrensel, V Ozkocaman, T Akbunar, M Demiray Nuclear medicine communications 24 (5), 537-542, 2003 | 38 | 2003 |
| Relation between insulin resistance and serum concentrations of IL-6 and TNF-α in overweight or obese women with early stage breast cancer G Gonullu, C Ersoy, A Ersoy, T Evrensel, B Basturk, E Kurt, B Oral, ... Cytokine 31 (4), 264-269, 2005 | 37 | 2005 |
| A case of primary spinal intramedullary lymphoma A Bekar, T Cordan, T Evrensel, Ş Tolunay Surgical neurology 55 (5), 261-264, 2001 | 36 | 2001 |
| Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer N Avci, A Deligonul, S Tolunay, E Cubukcu, O Fatih Olmez, A Ulas, ... J BUON 20 (1), 45-9, 2015 | 35 | 2015 |
| BRCA1/2 Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients G Cecener, U Egeli, B Tunca, E Erturk, S Ak, S Gokgoz, I Tasdelen, ... Cancer investigation 32 (8), 375-387, 2014 | 34 | 2014 |
